In 2020, Darzalex Faspro (the Sub-Q version) changed the game. The infusion time went from three hours (or an hour and a half ...

Merck's Keytruda wins EU approval for a new injectable form, offering greater treatment options for adults. Read more here.

This is the first and only subcutaneous immune checkpoint inhibitor in Europe that a health care provider can administer in ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

We are honored to introduce KEYTRUDA SC, the first and only subcutaneous immune checkpoint inhibitor in Europe that can be administered in one minute every three weeks or in two minutes every six ...

BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...

Roche has conditional marketing authorisation from the EC for Lunsumio SC for adults with R/R FL after at least two systemic ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

The clearance of Redemplo for a rare genetic disorder marks Arrowhead’s transition, after two decades, into a ...

A local research team pioneers the painless and convenient delivery of nanoparticles containing insulin with microneedles.